Treatment for Pneumocystis Pneumonia Recalled Due to Temperature Control Issue
The recall was initiated because the product had prolonged exposure to extremely cold weather during shipment.
All articles by Diana Ernst, RPh
Baricitinib Alone Authorized for COVID-19 Under Revised EUA
The update was based on data from the COV-BARRIER study.
Wynzora Cream Now Available for Plaque Psoriasis
Wynzora is a combination of calcipotriene, a synthetic vitamin D3 analogue, and betamethasone dipropionate, a corticosteroid.
Cholesterol Management Supplement Found to Contain Undeclared Rx Ingredient
Adverse events should be reported to the FDA’s MedWatch program.
Generic Version of Soolantra Cream Now Available
Ivermectin cream, 1% is indicated for the treatment of inflammatory lesions of rosacea.
Artesunate for Injection Now Available for Severe Malaria
Artesunate and its metabolite DHA are both active against the blood-stage asexual parasites and gametocytes of Plasmodium species including the chloroquine resistant strains.
FDA: Abuse/Misuse of OTC Nasal Decongestant Can Lead to Major Health Complications
Since January 1, 2000, there have been 460 documented cases of propylhexedrine abuse or misuse reported to US poison control centers.
FDA Expands Use of Bioelectronic Device ClearUp to Include Sinus Congestion
The bioelectronic device was previously approved for treating sinus pain due to allergic rhinitis.
FDA Cracks Down on Companies Selling Unapproved CBD Products
The products described in the warning letters are being marketed as topical pain therapies, though none have actually been evaluated by the FDA.
Guselkumab Benefits Observed Through 2 Years in Psoriatic Arthritis Trial
The DISCOVER-2 study aimed to evaluate multiple clinical outcomes including joint and skin symptoms and radiographic progression in patients with psoriatic arthritis.
- Loading...
Loading...
Loading... 
Loading...